Skip to main navigation

AnaptysBio

Investor Relations

  • About
    • Overview
    • Strategy
    • Management
    • Board of Directors
    • Research and Development Committee
    • Contact
  • Technology
    • Therapeutic Antibodies
    • Somatic Hypermutation
    • SHM Platform
    • Key Advantages
    • Publications
  • Pipeline
    • Overview
    • Etokimab
    • ANB019
    • Checkpoint Agonists
    • Partnerships
  • Investors / News
    • Overview
    • News
    • Events
    • Presentations
    • Governance
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Investor FAQs
    • Contact
  • Careers
    • Job Openings
    • Health and Financial Benefits Overview
  • Contact
Toggle

Governance - Sub nav

  • Documents
  • Board of Directors
  • Committee Composition

Committee Composition

Committee Composition

Audit Compensation Nominating and Corporate Governance
Dennis Fenton, Ph.D. Audit Compensation
Laura J. Hamill Audit Compensation
Hollings Renton Nominating and Corporate Governance
John Schmid Audit Compensation
James N. Topper, M.D., Ph.D Nominating and Corporate Governance
J. Anthony Ware, M.D. Audit Nominating and Corporate Governance
= Chairperson = Member = Financial Expert

Tools

  • Print

    Print

  • Email

    Email

  • RSS Feeds

    RSS Feeds

  • Email Alerts

    Email Alerts

  • Investor Contact

    Investor Contact

  • Document Request

    Document Request

 
  • About
    • Overview
    • Strategy
    • Management
    • Board of Directors
    • Therapeutic Advisory Board
  • Technology
    • Therapeutic Antibodies
    • Somatic Hypermutation
    • SHM Platform
    • Key Advantages
    • Publications
  • Pipeline
    • Overview
    • Etokimab
    • ANB019
    • Partnerships
  • Investors
    • Overview
    • News
    • Events
    • Goverance
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • FAQs
    • Contact
  • Careers
    • Job Openings
    • Health and Financial Benefits Overview
  • Contact
Connect LinkedIn Twitter
©2018 AnaptysBio, Inc. All Rights Reserved. Terms Of Use